Last edition
News about "Pharma Acquisition Deal "
Samsung Biologics Expands US Manufacturing with HGS Acquisition from GSK
Samsung Biologics has acquired Human Genome Sciences (HGS) from GSK, securing its first US-based manufacturing site and strengthening its global supply network. The company plans further investments to expand capacity and capabilities at the facility, reinforcing its long-term commitment to the US biopharmaceutical manufacturing ecosystem.
Pharma Acquisition Deal | 22/12/2025 | By News Bureau
Viva Biotech-Backed Arthrosi Enters USD 1.5 Billion Acquisition Deal with Sobi
Biovitrum AB (Sobi) has entered into an acquisition agreement with Viva Biotech–backed Arthrosi Therapeutics, with a total deal value of up to USD 1.5 billion, including USD 950 million upfront and up to USD 550 million in contingent payments, subject to closing in the first half of 2026.
Pharma Acquisition Deal | 16/12/2025 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy